# A Study of Brivaracetam in Subjects With Partial Onset Seizures

> **NCT00175929** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 157 (actual)

## Conditions studied

- Epilepsy, Focal

## Interventions

- **OTHER:** Placebo
- **DRUG:** Brivaracetam
- **DRUG:** Brivaracetam

## Key facts

- **NCT ID:** NCT00175929
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2015-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00175929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00175929, "A Study of Brivaracetam in Subjects With Partial Onset Seizures". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00175929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*